Clinical Trials
2 trialsNCT01458392 2022-10-05
Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Phase 2 Completed
NCT00996957 2013-03-18
Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Phase 1 Completed